This is an update of NICE Clinical guideline 27 (published June 2005)
|Scoping workshop:||19 March 2012|
|Consultation on draft scope with stakeholders:||03 April 2012 - 30 April 2012|
|Consultation on draft guideline with stakeholders:||20 November 2014 - 09 January 2015|
|Publication date:||June 2015|
|Centre for clinical practice lead:||Christine Carson|
|Guidelines commissioning manager:||
|Guidelines coordinator:||Thomas Feist|
|Patient involvement lead:||Emma Chambers|
|Implementation lead:||Louisa Regan|
|Guidelines Development Group:||The Guideline Development Group (GDG) oversees the development process.|
The National Collaborating Centre/Internal Development team may make a focussed call for evidence on specific clinical questions or sub-questions after completing its initial searches. It is able to make a call for evidence at any point during development of the guideline and stakeholders will usually be given 4 weeks to respond. The NCC will approach all registered stakeholders for this evidence.
The National Collaborating Centre/Internal Development team may not issue any calls for evidence for a guideline if the Guideline Development Group feels it is not necessary. In addition, the National Collaborating Centre/Internal Development team will accept relevant confidential data for consideration by the Guideline Development Group. The Health Economic plan, review questions and search strategies will be available on the website 5 weeks prior to the draft guideline consultation commencing.